Byotrol (#BYOT) – year-end trading update and proposed cancellation from AIM
- 2024-03-28 07:48:17
UK 06:22 Thursday, 1 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Previously writing on infection prevention and control products company Byotrol (BYOT), last year with the shares at 2.10p I noted balance sheet concerns and that I continued to avoid. The shares most recently closed at 0.90p and today “Launch of PROCESSUS® Instrument Decontamination” and “Trading Update” announcements… and what of the shares currently further lower at 0.725p?
Previously writing on anti-microbial hygiene technologies company Byotrol (BYOT), in August with the shares at 2.65p I concluded to continue to avoid. The shares last closed below 2p but are currently up more than 7.6% today at 2.10p on the back of a “Directorate Changes” announcement, so what’s the latest here?
Previously writing on antimicrobial company Byotrol (BYOT), in March with the shares up to 3.15p I questioned the overall performance despite it arguing a significant improvement in product sales. So what of now-announced results for its year ended 31st March 2022?
A trading update from infection prevention and control-focused company Byotrol (BYOT) commences, “Our second half performance (six months to 31 March 2022) is showing a significant improvement in product sales compared to our first half, and the order book remains strong into year end” and includes “if we do not conclude any large IP sales, we would expect overall revenues to be no less than £6m, with positive underlying EBITDA for the year… we expect our cash position at year end to be no less than £1m”. The shares have currently responded up to 3.15p, but what of they still down from above 5p as recently as December?...
Infection prevention and control products company Byotrol (BYOT) states that it “is pleased to announce” results for its half-year ended 30th September 2021. I previously concluded in April with the shares at 7p to avoid, they last closed at 5p...and are currently further lower at 4.275p. So what’s going on with trading?...
Infection and prevention control products company Byotrol (BYOT) “is pleased to announce an update on trading” – and the shares have currently responded more than 14% higher to 7p. What’s the story?...
Hello, Share Scramblers. My favourite hand sanitiser share Creightons (CRL) is still stuck in the mud. And though I’m in no hurry to sell my shares in that minnow, allow me to point you in the direction of another small company which makes antiseptic hand-washes. I’ve covered Byotrol (BYOT) before, but there’s no harm in an update...
Hello, Share Trudgers. I’ve recently been commending Creightons (CRL) for its exposure to the burgeoning hand sanitiser market. That share seems to have stalled for the time being, as the company has delayed publishing its numbers. So let’s have a look at another outfit in this promising market...
